Background Influenza virus remains a continuous and severe threat to public health
worldwide, and its prevention and treatment have always been a major international issue …

Influenza A viruses are a major threat to human health and inflict a significant public health
challenge worldwide. Hemagglutinin (HA) is the main contributor to the infectivity of the virus …

Broadly cross-reactive antibodies (Abs) that recognize conserved epitopes within the
influenza virus hemagglutinin (HA) stalk domain are of particular interest for their potential …

Due to continuous changes to its antigenic regions, influenza viruses can evade immune
detection and cause a significant amount of morbidity and mortality around the world …

Influenza virus infections pose a continuous threat to human health. Although vaccines
function as a preventive and protective tool, they may not be effective due to antigen drift or …

The pandemic threat posed by emerging zoonotic influenza A viruses necessitates
development of antiviral agents effective against various antigenic subtypes. Human …

ABSTRACT H6 influenza A viruses are enzootic and genetically diverse in both domestic
poultry and wild birds, occasionally causing spillovers to mammals, including humans …

Seasonal influenza viruses are highly contagious, leading to 290,000–650,000 mortalities
every year globally. Among the influenza viruses, influenza A virus (H3N2) has attracted …

The continued evolution of influenza viruses reduces the effectiveness of vaccination and
antiviral drugs. The identification of novel and universal agents for influenza prophylaxis and …

Background Human antibodies that interfere with the biological activity of haemagglutinins
(HAs) of influenza viruses have high potential as an antiviral agent. Methods Human single …